Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 144 articles:
HTML format



Single Articles


    July 2021
  1. KATAYAMA S, Tonai K, Minakata D, Nunomiya S, et al
    Pseudomembranous Invasive Tracheobronchial Aspergillosis.
    Am J Respir Crit Care Med. 2021 Jul 8. doi: 10.1164/rccm.202009-3659.
    PubMed    


    June 2021
  2. ROELENS M, Battista Migliori G, Rozanova L, Estill J, et al
    Evidence-based Definition for Extensively Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2021 Jun 9. doi: 10.1164/rccm.202009-3527.
    PubMed     Abstract available


    May 2021
  3. WELLS G, Glasgow JN, Nargan K, Lumamba K, et al
    microCT Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in 3D Granuloma Morphology.
    Am J Respir Crit Care Med. 2021 May 20. doi: 10.1164/rccm.202101-0032.
    PubMed     Abstract available


    April 2021

  4. Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2021;203:1045.
    PubMed    


  5. HUGHES DA, Price H, Rosenthal M, Davies JC, et al
    Pseudomonas aeruginosa in the Cystic Fibrosis Airway: Does It Deserve Its Reputation as a Predatory "Bully"?
    Am J Respir Crit Care Med. 2021;203:1027-1030.
    PubMed    


  6. HUDDART S, Savic RM, Cattamanchi A
    Is Glycemic Control the Secret to Tuberculosis Control?
    Am J Respir Crit Care Med. 2021 Apr 7. doi: 10.1164/rccm.202103-0703.
    PubMed    


  7. MILLER JO, Shih AR, Mino-Kenudson M, Taylor MS, et al
    Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.
    Am J Respir Crit Care Med. 2021;203:918-921.
    PubMed    


    March 2021
  8. BEHR MA, Kaufmann E, Duffin J, Edelstein PH, et al
    Latent Tuberculosis: Two Centuries of Confusion.
    Am J Respir Crit Care Med. 2021 Mar 24. doi: 10.1164/rccm.202011-4239.
    PubMed     Abstract available


  9. LIU Q, You N, Pan H, Shen Y, et al
    Glycemic Trajectories After Tuberculosis Diagnosis and Treatment Outcomes of New Tuberculosis Patients: A Prospective Study in Eastern China.
    Am J Respir Crit Care Med. 2021 Mar 11. doi: 10.1164/rccm.202007-2634.
    PubMed     Abstract available


  10. KENDALL EA, Shrestha S, Dowdy DW
    Reply to: Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202102-0367.
    PubMed    


  11. PIERCE CW
    Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202101-0227.
    PubMed    


  12. LE ROUX SP, Upton C, Vanker N, Dooley KE, et al
    Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.
    Am J Respir Crit Care Med. 2021;203:635-637.
    PubMed    


  13. IOVINO F, Henriques-Normark B
    Experimental Model for Studies of Pneumococcal Colonization in Older Adults.
    Am J Respir Crit Care Med. 2021;203:539-540.
    PubMed    


  14. JORTH P, Durfey S, Rezayat A, Garudathri J, et al
    Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting Pseudomonas aeruginosa.
    Am J Respir Crit Care Med. 2021;203:637-640.
    PubMed    


  15. BUETTI N, Mimoz O, Schwebel C, Ruckly S, et al
    Insertion Site and Infection Risk among Peripheral Arterial Catheters.
    Am J Respir Crit Care Med. 2021;203:630-633.
    PubMed    


  16. ADLER H, German EL, Mitsi E, Nikolaou E, et al
    Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.
    Am J Respir Crit Care Med. 2021;203:604-613.
    PubMed     Abstract available


    February 2021
  17. ESCALANTE P, Wilson JW
    New Diagnostics to Infer Risk in Tuberculosis: Is the Term Latent Tuberculosis Infection Obsolete?
    Am J Respir Crit Care Med. 2021 Feb 17. doi: 10.1164/rccm.202101-0131.
    PubMed    


    January 2021
  18. LOUGHLIN L, McAuley DF, Simpson AJ, McMullan R, et al
    Reply to: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202101-0026.
    PubMed    


  19. ABEREGG SK, Wolfe BM
    Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202012-4486.
    PubMed    


  20. HAMAD AM, Rea F, Haroon S
    Bronchial Atresia and Bronchogenic Cyst with Saprophytic Aspergilloma.
    Am J Respir Crit Care Med. 2021 Jan 25. doi: 10.1164/rccm.202010-3876.
    PubMed    


  21. AKSAMIT TR
    One Step Closer: Nontuberculous Mycobacterial Pulmonary Disease and Predicted Mortality-The BACES Score.
    Am J Respir Crit Care Med. 2021;203:163-164.
    PubMed    


  22. KIM HJ, Kwak N, Hong H, Kang N, et al
    BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease.
    Am J Respir Crit Care Med. 2021;203:230-236.
    PubMed     Abstract available


  23. HARRISON F, Smyth AR
    Professor Pangloss and the Pangenome: Does Staphylococcus aureus Have the Best of All Possible Worlds?
    Am J Respir Crit Care Med. 2021 Jan 11. doi: 10.1164/rccm.202012-4533.
    PubMed    


  24. MPANDE CAM, Musvosvi M, Rozot V, Mosito B, et al
    Antigen-specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection.
    Am J Respir Crit Care Med. 2021 Jan 6. doi: 10.1164/rccm.202007-2686.
    PubMed     Abstract available


  25. FRANKE MF, Khan P, Hewison C, Khan U, et al
    Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
    Am J Respir Crit Care Med. 2021;203:111-119.
    PubMed     Abstract available


    December 2020
  26. WAUTERS J, Lamoth F, Rijnders BJ, Calandra T, et al
    Invasive Pulmonary Aspergillosis Goes Viral Again?
    Am J Respir Crit Care Med. 2020 Dec 22. doi: 10.1164/rccm.202012-4413.
    PubMed    


  27. RAMOS-SEVILLANO E, Ercoli G, Felgner P, Ramiro de Assis R, et al
    Preclinical Development of Virulence Attenuated Streptococcus pneumoniae Strains Able to Enhance Protective Immunity Against Pneumococcal Infection.
    Am J Respir Crit Care Med. 2020 Dec 17. doi: 10.1164/rccm.202011-4161.
    PubMed    


  28. FEKKAR A, Lampros A, Mayaux J, Poignon C, et al
    Occurrence of Invasive Pulmonary Fungal Infections in Severe COVID-19 Patients Admitted to the ICU.
    Am J Respir Crit Care Med. 2020 Dec 2. doi: 10.1164/rccm.202009-3400.
    PubMed     Abstract available


  29. HOSODA C, Ishiguro T, Shimizu Y, Kanegane H, et al
    Mycobacterium genavense Infection Presenting as an Endobronchial Polyp and Upper Lobe Atelectasis.
    Am J Respir Crit Care Med. 2020;202:e144-e145.
    PubMed    


    November 2020
  30. KENDALL EA, Shrestha S, Dowdy DW
    The Epidemiological Importance of Subclinical Tuberculosis: A Critical Re-Appraisal.
    Am J Respir Crit Care Med. 2020 Nov 16. doi: 10.1164/rccm.202006-2394.
    PubMed     Abstract available


  31. WU BG, Sulaiman I, Tsay JJ, Perez L, et al
    Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary Th17 Response that Mitigates Susceptibility to Streptococcus pneumoniae.
    Am J Respir Crit Care Med. 2020 Nov 9. doi: 10.1164/rccm.202005-1596.
    PubMed     Abstract available


    October 2020
  32. SI X, Shi J
    Pulmonary and Skeletal Infection of Mycobacterium kansasii.
    Am J Respir Crit Care Med. 2020;202:1169-1170.
    PubMed    


  33. GARDNER AI, Haq IJ, Simpson AJ, Becker KA, et al
    Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1133-1145.
    PubMed     Abstract available


  34. OCAK S, d'Odemont JP
    Cavernoscopic Views of a Pleural Aspergillosis.
    Am J Respir Crit Care Med. 2020 Oct 6. doi: 10.1164/rccm.202004-0927.
    PubMed    


  35. HONDA JR
    Reply to Ward et al.: Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1062.
    PubMed    


  36. WARD C, Al Momani H, Perry A, Perry JD, et al
    Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1061.
    PubMed    


  37. SHALLER BD, Chen SB, Ho DY, Yu DH, et al
    Atypical Blastomycosis Masquerading as Lofgren Syndrome.
    Am J Respir Crit Care Med. 2020;202:1035-1036.
    PubMed    


    September 2020
  38. BLAIZE M, Mayaux J, Luyt CE, Lampros A, et al
    COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202007-2938.
    PubMed    


  39. MENON AA, Berg DD, Gay EB, Fredenburgh LE, et al
    Reply to: COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202008-3174.
    PubMed    



  40. Erratum: Lower Bacillus Calmette-Guerin Protection against Mycobacterium tuberculosis Infection after Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020;202:909-910.
    PubMed    


  41. CHANG KC, Yew WW
    ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
    Am J Respir Crit Care Med. 2020;202:777-778.
    PubMed    


  42. SOTGIU G, Battista Migliori G, Menzies D, Mase S, et al
    Reply to Chang and Yew.
    Am J Respir Crit Care Med. 2020;202:778-779.
    PubMed    


    August 2020
  43. WOLTER DJ, Ramsey BW
    Not Quite the Bully in the Schoolyard: Staphylococcus aureus Can Survive and Co-exist with Pseudomonas aeruginosa in the Cystic Fibrosis Lung.
    Am J Respir Crit Care Med. 2020 Aug 26. doi: 10.1164/rccm.202008-3077.
    PubMed    


  44. BURZYNSKI J, Keshavjee S
    Supporting a Comprehensive, International Approach to Global Tuberculosis Eradication is the Right Thing to Do.
    Am J Respir Crit Care Med. 2020 Aug 24. doi: 10.1164/rccm.202007-2976.
    PubMed    


  45. O'DONNELL M, Mathema B
    Operational Research on the Treatment of Drug-resistant Tuberculosis: Exciting Results that Need to be Protected.
    Am J Respir Crit Care Med. 2020 Aug 21. doi: 10.1164/rccm.202007-2974.
    PubMed    


  46. KYRIAZOPOULOU E, Liaskou-Antoniou L, Adamis G, Panagaki A, et al
    Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis: A Randomized Trial.
    Am J Respir Crit Care Med. 2020 Aug 6. doi: 10.1164/rccm.202004-1201.
    PubMed     Abstract available


  47. FISCHER AJ, Singh SB, LaMarche MM, Maakestad LJ, et al
    Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020 Aug 4. doi: 10.1164/rccm.202004-1322.
    PubMed     Abstract available


  48. DAWRS SN, Kautz M, Chan ED, Honda JR, et al
    Mycobacterium abscessus and Gastroesophageal Reflux: An In Vitro Study.
    Am J Respir Crit Care Med. 2020;202:466-469.
    PubMed    


  49. KOHLMAIER B, Strenger V, Egger M, Modl M, et al
    Persistent Stridor in a 10-Year-Old Patient with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:e72-e73.
    PubMed    


    July 2020
  50. TORRES A, Martin Loeches I
    Invasive Pulmonary Aspergillosis in Ventilator-Associated Pneumonia: The Hidden Enemy?
    Am J Respir Crit Care Med. 2020 Jul 30. doi: 10.1164/rccm.202006-2605.
    PubMed    


  51. SCHLUGER NW
    Prevention of Multidrug-resistant Tuberculosis in Close Contacts: Back to the Future?
    Am J Respir Crit Care Med. 2020 Jul 27. doi: 10.1164/rccm.202006-2488.
    PubMed    


  52. VAN ARKEL ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, et al
    Reply to: Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
    Am J Respir Crit Care Med. 2020 Jul 20. doi: 10.1164/rccm.202006-2241.
    PubMed    


  53. FEKKAR A, Poignon C, Blaize M, Lampros A, et al
    Fungal Infection During COVID-19: Does Aspergillus Mean Secondary Invasive Aspergillosis?
    Am J Respir Crit Care Med. 2020 Jul 20. doi: 10.1164/rccm.202005-1945.
    PubMed    


  54. VAN BIESEN S, Kwa D, Bosman RJ, Juffermans NP, et al
    Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Non-directed Bronchoalveolar Lavage.
    Am J Respir Crit Care Med. 2020 Jul 15. doi: 10.1164/rccm.202005-2018.
    PubMed    


  55. MENZIES NA, Bellerose M, Testa C, Swartwood N, et al
    Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States.
    Am J Respir Crit Care Med. 2020 Jul 9. doi: 10.1164/rccm.202003-0526.
    PubMed     Abstract available


  56. PODANY AT
    Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention.
    Am J Respir Crit Care Med. 2020 Jul 7. doi: 10.1164/rccm.202006-2144.
    PubMed    


  57. CUTLER T, Scales D, Levine W, Schluger N, et al
    A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jul 1. doi: 10.1164/rccm.202003-0828.
    PubMed    


  58. LOUGHLIN L, Hellyer TP, White PL, McAuley DF, et al
    Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK Intensive Care Units.
    Am J Respir Crit Care Med. 2020 Jul 1. doi: 10.1164/rccm.202002-0355.
    PubMed     Abstract available


    June 2020
  59. RODRIGUEZ CA, Sy KTL, Mitnick CD, Franke MF, et al
    Time Dependent Confounding in Tuberculosis Treatment Outcome Analyses: A Review of a Source of Bias.
    Am J Respir Crit Care Med. 2020 Jun 18. doi: 10.1164/rccm.202001-0220.
    PubMed    


  60. HUANG CC, Becerra MC, Calderon R, Contreras C, et al
    Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jun 17. doi: 10.1164/rccm.201908-1576.
    PubMed     Abstract available


  61. VAN DE VEERDONK FL, Wauters J, Verweij PE
    Invasive Aspergillus Tracheobronchitis Emerging as Highly Lethal Complication of Severe Influenza.
    Am J Respir Crit Care Med. 2020 Jun 10. doi: 10.1164/rccm.202005-1883.
    PubMed    



  62. Erratum: Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2020;201:1454.
    PubMed    


  63. JAIN S, Kumar P, Goyal JP
    Utility of Xpert Ultra on Different Respiratory Specimens in Children.
    Am J Respir Crit Care Med. 2020;201:1452.
    PubMed    


  64. ZAR HJ
    Reply to Jain et al.: Utility of Xpert Ultra on Different Respiratory Specimens in Children.
    Am J Respir Crit Care Med. 2020;201:1452-1453.
    PubMed    


    May 2020
  65. HIBINO M, Horiuchi S, Kondo T
    Localized Tracheal Cryptococcosis Misdiagnosed as Severe Refractory Asthma.
    Am J Respir Crit Care Med. 2020 May 27. doi: 10.1164/rccm.202001-0032.
    PubMed    


  66. SCHEUERMANN L, Pei G, Domaszewska T, Zyla J, et al
    Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis.
    Am J Respir Crit Care Med. 2020 May 18. doi: 10.1164/rccm.201910-2063.
    PubMed     Abstract available


  67. HIBMA JE, Radtke KK, Dorman SE, Jindani A, et al
    Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.201912-2489.
    PubMed     Abstract available


  68. MENON AA, Berg DD, Brea EJ, Deutsch AJ, et al
    A Case of COVID-19 and Pneumocystis jirovecii Co-infection.
    Am J Respir Crit Care Med. 2020 May 15. doi: 10.1164/rccm.202003-0766.
    PubMed    


  69. DAVIDS M, Pooran A, Hermann C, Mottay L, et al
    A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guerin.
    Am J Respir Crit Care Med. 2020;201:1277-1291.
    PubMed     Abstract available


  70. NYGA R, Maizel J, Nseir S, Chouaki T, et al
    Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza.
    Am J Respir Crit Care Med. 2020 May 14. doi: 10.1164/rccm.201910-1931.
    PubMed     Abstract available


  71. VAN ARKEL ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, et al
    COVID-19 Associated Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 May 12. doi: 10.1164/rccm.202004-1038.
    PubMed    


  72. KLOUDA T, Chiel L, Davis J, Boyer D, et al
    Pediatric Lung Transplant: Influences of Viral and Fungal Infections on Outcomes and Viral Markers as a Predictor of Outcome.
    Am J Respir Crit Care Med. 2020;201:1146-1148.
    PubMed    


  73. SHAH P, Woytanowski JR, Hadeh A, Sockrider M, et al
    Pneumococcal (Pneumonia) Vaccines.
    Am J Respir Crit Care Med. 2020;201:P17-P18.
    PubMed    


    April 2020
  74. DHEDA K, Davids M
    Latent Tuberculosis Infection-associated Immunodiagnostic Test Responses as Biomarkers of Incipient Tuberculosis: Fruitful or Futile?
    Am J Respir Crit Care Med. 2020;201:895-898.
    PubMed    


  75. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Reply to: Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0855.
    PubMed    


  76. SWINDELLS S, Hughes M, Chaisson RE
    Trials of Tuberculosis Preventive Therapy in People with HIV Infection.
    Am J Respir Crit Care Med. 2020 Apr 13. doi: 10.1164/rccm.202003-0761.
    PubMed    


    March 2020
  77. DOOLEY KE, Miyahara S, von Groote-Bidlingmaier F, Sun X, et al
    Reply to: High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202002-0359.
    PubMed    


  78. DECROO T, de Jong BC, Piubello A, Souleymane MB, et al
    High-dose First-line Treatment Regimen for Recurrent Rifampicin-susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2020 Mar 4. doi: 10.1164/rccm.202001-0201.
    PubMed    


    February 2020
  79. GAO YH, Abo Leyah H, Finch S, Lonergan M, et al
    The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis.
    Am J Respir Crit Care Med. 2020 Feb 25. doi: 10.1164/rccm.201910-1972.
    PubMed     Abstract available


  80. KENG LT, Lee CF
    Ultrasound-Guided Transthoracic Needle Aspiration to Diagnose Invasive Pulmonary Aspergillosis.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202001-0008.
    PubMed    


  81. WASSERMAN S, Furin J
    Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations.
    Am J Respir Crit Care Med. 2020 Feb 20. doi: 10.1164/rccm.202002-0264.
    PubMed    



  82. Erratum: Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2020;201:500-501.
    PubMed    


  83. VERNON A, Bishai W
    Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?
    Am J Respir Crit Care Med. 2020;201:405-406.
    PubMed    


  84. ANDRES S, Merker M, Heyckendorf J, Kalsdorf B, et al
    Bedaquiline-resistant Tuberculosis: Dark Clouds on the Horizon.
    Am J Respir Crit Care Med. 2020 Feb 13. doi: 10.1164/rccm.201909-1819.
    PubMed    


    January 2020
  85. DE JAGER VR, Vanker N, van der Merwe L, van Brakel E, et al
    Optimising beta-lactams Against Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jan 10. doi: 10.1164/rccm.201911-2149.
    PubMed    


  86. VERRALL AJ, Chaidir L, Ruesen C, Apriani L, et al
    Lower BCG Protection Against Mycobacterium tuberculosis Infection After Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020 Jan 8. doi: 10.1164/rccm.201912-2349.
    PubMed    


  87. NICHOLS DP, Moss RB
    Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2309.
    PubMed    


  88. MCSHANE H
    Controlled Human Infection Models - Is it Really Feasible to Give People Tuberculosis?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2408.
    PubMed    


    December 2019
  89. GUPTA RK, Lipman M, Jackson C, Sitch A, et al
    Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study.
    Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201905-0969.
    PubMed     Abstract available


  90. ABUBAKAR I, Cobelens FG, Rangaka MX
    The Risk of Falsely Declaring Non-Inferiority of Novel Latent Tuberculosis Treatment in Large Trials.
    Am J Respir Crit Care Med. 2019 Dec 9. doi: 10.1164/rccm.201911-2258.
    PubMed    


    November 2019
  91. NISHIZAWA S, Tobino K
    Asymptomatic Tuberculous Pleurisy Mimicking Mesothelioma.
    Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201906-1223.
    PubMed    


  92. BREUER O, Schultz A, Garratt LW, Turkovic L, et al
    Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019 Nov 20. doi: 10.1164/rccm.201908-1585.
    PubMed     Abstract available


  93. NAHID P, Mase SR, Migliori GB, Sotgiu G, et al
    Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
    Am J Respir Crit Care Med. 2019;200:e93-e142.
    PubMed     Abstract available


  94. STOUT JE, Turner NA, Belknap RW, Horsburgh CR, et al
    Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201908-1606.
    PubMed     Abstract available


  95. NARITA M, Sullivan Meissner J, Burzynski J
    Use of Modeling to Inform Tuberculosis Elimination Strategies.
    Am J Respir Crit Care Med. 2019 Nov 7. doi: 10.1164/rccm.201910-2061.
    PubMed    


    October 2019
  96. BROWN JS
    Improving Pulmonary Immunity to Bacterial Pathogens Through Streptococcus pneumoniae Colonisation of the Nasopharynx.
    Am J Respir Crit Care Med. 2019 Oct 30. doi: 10.1164/rccm.201910-2047.
    PubMed    


  97. TEZERA LB, Mansour S, Elkington P
    Reconsidering the Optimal Immune Response to Mycobacterium tuberculosis.
    Am J Respir Crit Care Med. 2019 Oct 28. doi: 10.1164/rccm.201908-1506.
    PubMed     Abstract available


  98. FOREMAN TW, Bucsan AN, Mehra S, Peloquin C, et al
    Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2019 Oct 24. doi: 10.1164/rccm.201903-0646.
    PubMed     Abstract available


  99. MENZIES NA, Parriott A, Shrestha S, Dowdy DW, et al
    Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California.
    Am J Respir Crit Care Med. 2019 Oct 18. doi: 10.1164/rccm.201907-1289.
    PubMed     Abstract available


    September 2019
  100. SURETTE MG, Bowdish DME
    Loss of Microbial Topography Precedes Infection in Infants.
    Am J Respir Crit Care Med. 2019;200:660-662.
    PubMed    


  101. SAGAR AS, Dodge DL, Salahuddin M, Warner MT, et al
    Pleural Diseases: Pleurodesis via Indwelling Pleural Catheter, Dasatinib-induced Pleural Effusion, and IL-27 in Tuberculosis Pleural Effusion.
    Am J Respir Crit Care Med. 2019;200:771-773.
    PubMed    


  102. KOTTHOFF-BURRELL E
    Candidemia (Blood Infection) and Other Candida Infections.
    Am J Respir Crit Care Med. 2019;200:P9-P10.
    PubMed    


    August 2019
  103. ORTON CM, Garner JL, Desai SR, Kemp SV, et al
    Aspergillus Cavitation Complicating Endobronchial Lung Volume Reduction Coil Placement.
    Am J Respir Crit Care Med. 2019 Aug 30. doi: 10.1164/rccm.201906-1176.
    PubMed    


  104. SCHAAF HS, Marais BJ
    The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children.
    Am J Respir Crit Care Med. 2019 Aug 6. doi: 10.1164/rccm.201907-1492.
    PubMed    


  105. ZAR HJ, Workman LJ, Prins M, Bateman LJ, et al
    Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
    Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201904-0772.
    PubMed     Abstract available


  106. PARIKH R, Belok SH, Swamy L, Reardon CC, et al
    Adjunctive Therapies in the Management of Septic Shock.
    Am J Respir Crit Care Med. 2019;200:381-383.
    PubMed    


    July 2019
  107. PRAZAK J, Iten M, Cameron DR, Save J, et al
    Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.
    Am J Respir Crit Care Med. 2019 Jul 1. doi: 10.1164/rccm.201812-2372.
    PubMed     Abstract available


    June 2019
  108. MEEGAN JE, Bastarache JA
    NET Gain for Sepsis Research: New Approach to Assess Neutrophil Function in Patients.
    Am J Respir Crit Care Med. 2019 Jun 11. doi: 10.1164/rccm.201905-1074.
    PubMed    


    May 2019
  109. SEMLER MW, Singer M
    Deconstructing Hyperlactatemia in Sepsis Using ScvO2 and Base Deficit.
    Am J Respir Crit Care Med. 2019 May 19. doi: 10.1164/rccm.201904-0899.
    PubMed    


  110. GAUTAM S, Sharma L, Dela Cruz CS
    Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia.
    Am J Respir Crit Care Med. 2019;199:1178-1181.
    PubMed    


  111. SANDERS DB, Nichols DP
    Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2019;199:1181-1182.
    PubMed    


  112. NIEDERMAN MS, Nair GB, Matt U, Herold S, et al
    Update in Lung Infections and Tuberculosis 2018.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0606.
    PubMed    


  113. VAN DE GROEP K, Verboom DM, van de Veerdonk FL, Haas PA, et al
    Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: the Role of Plasma Galactomannan.
    Am J Respir Crit Care Med. 2019 May 1. doi: 10.1164/rccm.201903-0587.
    PubMed    


  114. RUSSELL JA, Gordon AC, Walley KR
    Early May Be Better: Early Low-Dose Norepinephrine in Septic Shock.
    Am J Respir Crit Care Med. 2019;199:1049-1051.
    PubMed    


    April 2019
  115. KRANZER K, Kalsdorf B, Heyckendorf J, Andres S, et al
    New WHO Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?
    Am J Respir Crit Care Med. 2019 Apr 26. doi: 10.1164/rccm.201902-0260.
    PubMed    


  116. GUPTA E, Jacobs MD, George G, Roman J, et al
    Beyond the ICU: Frailty and Post-ICU Disability. Healthcare Use after Acute Respiratory Distress Syndrome and Severe Sepsis.
    Am J Respir Crit Care Med. 2019;199:1028-1030.
    PubMed    


    March 2019
  117. PRESCOTT HC
    Identifying Sepsis Subtypes from Routine Clinical Data.
    Am J Respir Crit Care Med. 2019 Mar 8. doi: 10.1164/rccm.201903-0532.
    PubMed    


    January 2019
  118. DHEDA K, Lenders L, Srivastava S, Magombedze G, et al
    Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing.
    Am J Respir Crit Care Med. 2019 Jan 29. doi: 10.1164/rccm.201807-1361.
    PubMed     Abstract available


  119. TE BRAKE LHM, Boeree MJ, Aarnoutse RE
    Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201811-2101.
    PubMed    


  120. VELASQUEZ GE, Brooks MB, Coit JM, Sanchez Garavito E, et al
    Reply to: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2019 Jan 15. doi: 10.1164/rccm.201812-2281.
    PubMed    


  121. HANSEN C, Scupp T, Nelson J, Brainard J, et al
    Implications of Procalcitonin Testing in Critically Ill Patients with Sepsis.
    Am J Respir Crit Care Med. 2019;199:232-234.
    PubMed    


    December 2018
  122. SCICLUNA BP, Baillie JK
    The Search for Efficacious New Therapies in Sepsis Needs to Embrace Heterogeneity.
    Am J Respir Crit Care Med. 2018 Dec 12. doi: 10.1164/rccm.201811-2148.
    PubMed    


    November 2018
  123. CONSONNI F, Nacoti M, Amini M, Vedovati S, et al
    Severe Necrotizing Staphylococcal Pneumonia with Late Life-Threatening Tracheo-Bronchial Involvement in Infant.
    Am J Respir Crit Care Med. 2018 Nov 15. doi: 10.1164/rccm.201803-0507.
    PubMed    


  124. JONES TK, Wong HR, Meyer NJ
    HDL Cholesterol: A "Pathogen Lipid Sink" for Sepsis?
    Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201811-2084.
    PubMed    


    October 2018
  125. SCHLUGER NW
    Tuberculosis Elimination, Research, and Respect for Persons.
    Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201809-1623.
    PubMed    


  126. KESHAVJEE S, Amanullah F, Cattamanchi A, Chaisson R, et al
    Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Am J Respir Crit Care Med. 2018 Oct 18. doi: 10.1164/rccm.201806-1053.
    PubMed     Abstract available


  127. MARTINEZ L, Andrews JR
    Improving Tuberculosis Case Finding in Persons Living with Advanced HIV through New Diagnostic Algorithms.
    Am J Respir Crit Care Med. 2018 Oct 1. doi: 10.1164/rccm.201809-1702.
    PubMed    


    September 2018
  128. YOON C, Semitala FC, Asege L, Katende J, et al
    Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0490.
    PubMed     Abstract available


    August 2018
  129. ELKINGTON PT, Bateman AC, Thomas GJ, Ottensmeier CH, et al
    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.
    Am J Respir Crit Care Med. 2018 Aug 24. doi: 10.1164/rccm.201807-1250.
    PubMed    


    June 2018
  130. VELASQUEZ GE, Brooks MB, Coit JM, Pertinez H, et al
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2018 Jun 29. doi: 10.1164/rccm.201712-2524.
    PubMed     Abstract available


  131. DHEDA K, Lenders L, Magombedze G, Srivastava S, et al
    Drug Penetration Gradients Associated with Acquired Drug Resistance in Tuberculosis Patients.
    Am J Respir Crit Care Med. 2018 Jun 7. doi: 10.1164/rccm.201711-2333.
    PubMed     Abstract available


    May 2018
  132. LAN F, Zhang N, Holtappels G, Ruyck N, et al
    Staphylococcus aureus Induces Mucosal Type 2 Immune Response via Epithelial Cell Derived Cytokines.
    Am J Respir Crit Care Med. 2018 May 16. doi: 10.1164/rccm.201710-2112.
    PubMed     Abstract available


    April 2018
  133. MONEDERO-RECUERO I
    Drug-resistant Tuberculosis in Europe. What are We Waiting for?
    Am J Respir Crit Care Med. 2018 Apr 18. doi: 10.1164/rccm.201803-0497.
    PubMed    


  134. SULIMAN S, Thompson E, Sutherland J, Weiner Rd J, et al
    Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
    Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340.
    PubMed     Abstract available


    March 2018
  135. ABUBAKAR I, Gupta RK, Rangaka MX, Lipman M, et al
    Update in Tuberculosis and Non-tuberculous Mycobacteria 2017.
    Am J Respir Crit Care Med. 2018 Mar 14. doi: 10.1164/rccm.201801-0106.
    PubMed    


  136. COX D, Keane J
    Platelets and Tuberculosis: Small Cells, Not So Innocent Bystanders.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201802-0279.
    PubMed    


  137. GUNTHER G, van Leth F, Alexandru S, Altet N, et al
    Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries.
    Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141.
    PubMed     Abstract available


    February 2018
  138. SCHWANDER S, Keane J
    Cause or Effect - the Elusive Role of Regulatory T Cells in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201802-0233.
    PubMed    


  139. FOX KA, Kirwan DE, Whittington AM, Krishnan N, et al
    Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
    Am J Respir Crit Care Med. 2018 Feb 8. doi: 10.1164/rccm.201710-2102.
    PubMed     Abstract available


    December 2017
  140. ERNST JD
    Float Like Bacilli, STING Like a B: Type I Interferons in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Dec 20. doi: 10.1164/rccm.201712-2368.
    PubMed    



  141. What Is Sepsis?
    Am J Respir Crit Care Med. 2017;196:P21-P22.
    PubMed    


    November 2017
  142. BENARD A, Sakwa I, Schierloh P, Colom A, et al
    B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Nov 21. doi: 10.1164/rccm.201707-1475.
    PubMed     Abstract available


    October 2017
  143. DIVANGAHI M, Behr MA
    Cracking the Vaccine Code in Tuberculosis.
    Am J Respir Crit Care Med. 2017 Oct 18. doi: 10.1164/rccm.201707-1489.
    PubMed     Abstract available


  144. MARTINEZ L, Handel A, Shen Y, Chakraburty S, et al
    A Prospective Validation of a Clinical Algorithm to Detect Tuberculosis in Child Contacts.
    Am J Respir Crit Care Med. 2017 Oct 16. doi: 10.1164/rccm.201706-1210.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: